Ptla stock price forecast

Stock Price Forecast for PTLA: Portola Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still 

View live PORTOLA PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, PTLA financials and market news. View live PORTOLA PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, PTLA financials and market news. Portola Pharmaceuticals has nearly everything I look for in a setup. PTLA Price Target | Portola Pharma Stock Forecast & Ratings See Portola Pharma price target based on 7 analysts offering 12 month price targets for Portola Pharma in the last 3 months. The average price target is $20.33 with a high forecast of $31.00 and a low forecast of $14.00. The average price target represents a 185.13% increase from the last price of $7.13. PTLA - Portola Pharma Stock Price - Barchart.com

27 Feb 2020 Inc. (PTLA) is an asset to your trade with current Target Price of $23.33. By The 1-year high price for the company's stock is recorded $37.95 on Portola Pharmaceuticals, Inc. (PTLA) full year performance was -58.65%.

27 Feb 2020 Inc. (PTLA) is an asset to your trade with current Target Price of $23.33. By The 1-year high price for the company's stock is recorded $37.95 on Portola Pharmaceuticals, Inc. (PTLA) full year performance was -58.65%. 27 Feb 2020 Portola Pharma (PTLA) yesterday, Phil Nadeau from Cowen & Co. maintained a Buy rating on Portola Pharma, with a price target of $30.00. 19 Mar 2020 Additionally, PTLA shares got another “Neutral” rating from Credit Suisse, setting a target price of $35 on the company's shares, according to  When there are few resistance areas, stocks may quickly rise to targets. TARGET 2. Price: 8.04 Profit: 12.8%. P/L Ratio: 2.3 : 1 - Fair. (Extreme rally).

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Find real-time OPK - OPKO Health Inc stock quotes, company profile, news and forecasts from CNN Business. OPK - OPKO Health Inc Stock quote - CNNMoney.com Markets Portola Pharmaceuticals (PTLA) forecast target analysis ... Technical analysis forecast for Portola Pharmaceuticals Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Portola Pharmaceuticals PTLA at this time. Stock is falling and might fall more. Stock is slowly closing in and getting inside a small range. PTLA - Portola Pharma Stock Price - Barchart.com It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Portola Pharmaceuticals Inc (NASDAQ:PTLA) Shares Acquired ...

60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Top price targets Weekly price targets Monthly price targets Yearly price targets Intraday price targets . As on 07 Fri Feb 2020 Current price of Portola Pharmaceuticals, Inc. PTLA is 13.15 and trend of stock is towards downside and stock can be sold for price targets of 12.12, 11.84 Here are the top Institutional holders of Portola ...

PTLA | Portola Pharmaceuticals Inc. Analyst Estimates ...

Jun 13, 2017 · We picked up Portola Pharmaceuticals (NASDAQ:PTLA) in the portfolio in August 2016 when the investors had dumped the stock after receiving CRL … Market cap of Portola Pharmaceuticals Inc. [PTLA] reaches ... Mar 17, 2020 · Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PTLA shares is $20.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PTLA stock is a recommendation set at 2.30. NASDAQ:PTLA Portola Pharmaceuticals, Inc. Stock Analysis ... Portola Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of novel therapeutics in the areas of thrombosis …

The Distribution Yield is the trailing 12-Month End Yield derived by adding the trailing 12-month's income distributions and dividing the total by the last month's ending share price. Income refers to interest payments from fixed-income ETFs and dividend payments from stock-based ETFs. 10 Top Portola Pharmaceuticals PTLA Share price target ... Top price targets Weekly price targets Monthly price targets Yearly price targets Intraday price targets . As on 07 Fri Feb 2020 Current price of Portola Pharmaceuticals, Inc. PTLA is 13.15 and trend of stock is towards downside and stock can be sold for price targets of 12.12, 11.84 Here are the top Institutional holders of Portola ...